Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults

Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults

Two antigenically distinct influenza B lineage viruses (Yamagata/Victoria) have been co-circulating globally since the mid-1980s. The quadrivalent influenza vaccine (QIV) may provide better protection against unpredictable B strains. We conducted a randomized, double-blind, phase III trial to evalua...

Full description

Bibliographic Details
Main Authors: Joon Young Song, Jacob Lee, Heung Jeong Woo, Seong-Heon Wie, Jin Soo Lee, Shin Woo Kim, Tae Hyong Kim, Sook-In Jung, Ji Yun Noh, Won Suk Choi, Hee Jin Cheong, Woo Joo Kim
Format: Article
Language:English
Published: Taylor & Francis Group 2019-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
inactivated quadrivalent influenza vaccine
influenza b
victoria lineage
yamagata lineage
Online Access:http://dx.doi.org/10.1080/21645515.2018.1536589

Internet

http://dx.doi.org/10.1080/21645515.2018.1536589

Similar Items